Showing results (111-120 of 130) with videos related to
Sort By:
Pageof 13
Nature Communications|May 22, 2026
Tumor sialylation regulates G-CSF stability and promotes neutrophil-mediated immunosuppression in breast cancerStefan Mereiter, Gustav Jonsson, Tiago Oliveira, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2022
Prognosis of Patients With Primary Melanoma Stage I and II According to American Joint Committee on Cancer Version 8 Validated in Two Independent Cohorts: Implications for Adjuvant TreatmentClaus Garbe, Ulrike Keim, Teresa Amaral, et al.Nature Communications|March 2, 2017
Spatiotemporally restricted arenavirus replication induces immune surveillance and type I interferon-dependent tumour regressionHalime Kalkavan, Piyush Sharma, Stefan Kasper, et al.Journal of Autoimmunity|October 12, 2023
Autoreactive T cells targeting type II pneumocyte antigens in COVID-19 convalescent patientsChrista Lichtensteiger, Maximilian Koblischke, Fiamma Berner, et al.Molecular Cancer|December 16, 2023
Acidosis-mediated increase in IFN-γ-induced PD-L1 expression on cancer cells as an immune escape mechanism in solid tumorsPhilipp Knopf, Dimitri Stowbur, Sabrina H L Hoffmann, et al.Molecular Cancer|December 10, 2025
Immune cell senescence drives responsiveness to immunotherapy in melanomaPavlos Pantelis, Dimitrios Christos Tremoulis, Konstantinos Evangelou, et al.Nature Communications|July 2, 2026
Years of life lost in patients with a false-negative diagnosis of primary melanoma. A prospective study of the German Central Malignant Melanoma Registry involving 9063 patients over 28 yearsClaus Garbe, Ulrike Keim, Teresa Amaral, et al.JAMA Oncology|April 26, 2019
Association of Checkpoint Inhibitor-Induced Toxic Effects With Shared Cancer and Tissue Antigens in Non-Small Cell Lung CancerFiamma Berner, David Bomze, Stefan Diem, et al.Gastroenterology|September 29, 2024
Multimodal Profiling of Peripheral Blood Identifies Proliferating Circulating Effector CD4+ T Cells as Predictors for Response to Integrin α4β7-Blocking Therapy in Inflammatory Bowel DiseaseVeronika Horn, Camila A Cancino, Lisa M Steinheuer, et al.Nature Cancer|July 31, 2023
Interleukin 17 signaling supports clinical benefit of dual CTLA-4 and PD-1 checkpoint inhibition in melanomaRenáta Váraljai, Lisa Zimmer, Yahya Al-Matary, et al.Pageof 13